Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads worldwide and
leads to an unprecedented medical burden and lives lost. Neutralizing antibodies provide …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike is a trimer of
S1/S2 heterodimers with three receptor-binding domains (RBDs) at the S1 subunit for …

Global health and economy are deeply influenced by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and its newly emerging variants. Nanobodies with nanometer …

SARS-CoV-2 remains a global threat to human health particularly as escape mutants
emerge. There is an unmet need for effective treatments against COVID-19 for which …

With more than 6.9 M confirmed cases and~ 400 K deaths as on June 8, 2020 (1), COVID-
19, ushered in by the SARS-CoV-2 has projected itself as a microscopic-holocaust, much …

The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
had a large impact on global health, travel, and economy. Therefore, preventative and …

Cost-effective, efficacious therapeutics are urgently needed to combat the COVID-19
pandemic. In this study, we used camelid immunization and proteomics to identify a large …

Effective therapies are urgently needed for the SARS-CoV-2/COVID19 pandemic. We
identified panels of fully human monoclonal antibodies (mAbs) from eight large …

The new SARS-CoV-2 variant of concern “Omicron” was recently spotted in South Africa and
spread quickly around the world due to its enhanced transmissibility. The variant became …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs)
continue to wreak havoc across the globe. Higher transmissibility and immunologic …